SKS. I. Kirkilevskyi

S. I. Kirkilevskyi

*This is an algorithmically generated author record based on publicly available information.

S. I. Kirkilevskyi has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The impact of the tumor microenvironment on the selection of systemic therapy regimens in patients with stage IVa–b gastric cancer based on molecular genetic characteristics

    by P.I. Gordiichuk, Д.о. Морський, S.I. Kirkilevsky, M.P. Gordiichuk, П.о. Король, D.V. Melnyk, П.і. Гордійчук, С.і. Кіркілевський

    Background. Gastric cancer is more frequently diagnosed at an advanced stage; in Ukraine, nearly 60% of patients have stage III or IV disease at the time of diagnosis, when surgical treatment is either inappropriate or not feasible. Conventional chemotherapy provides only limited improvement in survival; therefore, interest in targeted therapy and immunotherapy as promising treatment modalities is increasing. Purpose – was to present the results of histological, immunohistochemical, and molecular genetic characteristics of gastric cancer and the tumor microenvironment as predictors of prognosis and selection of systemic medical treatment. Materials and Methods. Data retrieval for the review was conducted in accordance with the PRISMA-ScR guidelines. A systematic search was performed in PubMed, Scopus, Google Scholar, and Embase (from 2017 to the present) and was supplemented by a review of major clinical guidelines (NCCN, ESMO) published over the past five years. Results. The results of the literature search over the past ten years demonstrated that an integrated assessment of histological and immunohistochemical characteristics enables more accurate classification of gastric cancer, prediction of its biological aggressiveness, and selection of individualized therapeutic approaches. Moreover, morphological analysis of the tumor – stroma ratio at the invasive front allows for a more precise interpretation of the clinical significance of the tumor microenvironment (TME) and facilitates the identification of novel prognostic markers associated with gastric cancer progression. Molecular genetic characteristics of the tumor (HER2 status, PD-L1 expression [CPS], MSI/MMR status, EBV positivity, and CLDN18.2 expression) determine the feasibility of personalized therapy. In metastatic gastric cancer, the integration of molecular profiling with TME characteristics enables a rational choice among anti-HER2 strategies, antiangiogenic therapy, immunotherapy, or their combinations. Conclusions. Comprehensive characterization of the tumor microenvironment, along with the immunohistochemical and molecular genetic landscape of the tumor stage IVa,b gastric cancer, should become a standard of clinical practice to enable personalized systemic therapy and improve survival outcomes.

  • Open Access

    INTRODUCTION TO THE TNM-INDEPENDENT EVALUATION SYSTEM

    by S. I. Kirkilevsky, V. O. Polyasny, A. O. Mashukov, L. А. Kovalevskaya

    TNM-independent survival of patients with gastric cancer is a new phenomenon in the system of life expectancy evaluation of patients operated on for gastric cancer (GC). The more pronounced is the lymphocytic infiltration of the tumor, the higher the survival of the cancer patient. To determine the level of the immunoscore index, abbreviated IS, the presence of CD3, CD8, CD 68, CD 163 cells in the following tumor areas are studied: TS – tumor stroma, TN – central tumor, TM – tumor edge, AG – all localizations. CD3 is a marker of T lymphocytes, including CD4 + T helpers. CD8 is a marker of cytotoxic T lymphocytes. TAM, tumor-associated macrophages were classified into M1 (classically activated, CD68) and M2 (alternatively activated, CD163) cells. A total of 25,495 specific cells were identified during the study, of which 13,829 were macrophages and 1,166 were T-lymphocytes. CD3 predominated in tumor stroma (3919 > 3333 of all detected), CD8 T-killers also predominated in tumor stroma (2447 > 1967 of all detected) , CD68 M1 macrophages, in contrast, predominated in the tumor “nest” (4760 > 4314 of all detected) and CD163 M2 macrophages also predominated in the central areas of the tumor (2408 > 2347 of all detected in the process). Only the saturation of macrophages in the tumor nest correlated with a favorable prognosis, T-lymphocytic infiltration gave multidirectional trends, regardless of their location. Infiltration affected survival regardless of stage of cervical cancer. Preliminary conclusions have been made that the study of IS is necessary both in terms of the impact on patient survival, both as a prognostic factor and with the prospect of more active administration and use of immunotargent drugs (ITPs), such as pembrolizumab, in the future.

  • Open Access

    Immunoscore and personification of chemotherapeutic treatment in patients with gastric cancer

    by S. I. Kirkilevskyi, O. M. Sulaeva, O. V. Lukyanchuk, A.G. Lurin, A. O. Mashukov, O. I. Tkachenko, О. М. Згура, O.A. Bilenko, V. E. Maksimovskyi, D. V. Ratsiborskyi, et al.

    Background. There are a few indications known in the world to administer immunotherapy (IT) via immune checkpoint inhibitors (ICIs). Prescribing IT by means of ICIs in gastric cancer (GC) results from PDL1 ligand expression on tumor cells; high tumor mutation burden; GC with microsatellite instability MSI-h or DNA mismatch repair (MMR) failure; T-killer immunoscore (IS). Purpose. To study the composition of the immunocellular phenotype of gastric malignancies. Materials and methods. The paper presents the outcomes of a clinical study conducted at the premises of Thoracic Tumors Research Department of National Cancer Institute and Abdominal Oncosurgery Department of Municipal Non-Profit Enterprise “Odessa Regional Oncology Dispensary” of Odessa Regional Council enrolling 221 patients operated on for gastric cancer within the period from 2007 to 2013. The average age was 60.88 ± 10.5, men – 180, women – 41. A total of 143 gastrectomies and 78 distal subtotal resections were performed. The study group of patients to investigate IS consisted of 22 patients with gastric cancer. At the first stage, the density of immunocompetent TILs or TIMs were determined, where TILs quantified tumor-infiltrating lymphocytes and TIMs counted the number of tumor-infiltrating macrophages. The second step was assessing the severity of infiltration by immune cells of two compartments: the central areas of the tumor (CT) and around the edge of the tumor invasion (IM), i. e. in the peritumoral stroma. Results and discussion. All patients included in the study were radically operated on. The tumors removed during surgery were examined by means of immunoscore. A particularly high correlation was observed between PD-L1 expression in cells and CD8 T-lymphocytes in tumor nest – 0.81. Immunoscore effect on the prognosis was 0.64. A negative high correlation was assessed between the concentration of M2 CD163 macrophages in the tumor and the metastases to regional lymph nodes – 0.65. A particularly high correlation between the concentration of CD3 and CD8 in the central areas of the tumor reaching 0.95. A particularly high correlation between PD-L1 expression in cells and CD3 cells in tumor nest – 0.84. The correlation between CD3 and CD8 in the tumor stroma was particularly high, 0.87. Conclusions. The study of immunoscore is essential both in terms of the impact on patient survival, as a prognostic factor, and with a view to more active administering and using immune-targeted drugs in the future.